Type 2 Diabetes: What the Medicines Actually Do
Six drug classes lower blood glucose by six different mechanisms, with very different side effect profiles and prices. Here is a plain account of what each one does and where it fits.
What is Type 2 Diabetes?
Type 2 diabetes is a condition in which the body still produces insulin but no longer responds to it properly, and the pancreas gradually loses the capacity to compensate. Both halves of that sentence matter, because they explain why treatment changes over time. Early on, the dominant problem is insulin resistance, and medicines that improve sensitivity or reduce the glucose the liver releases work well. Later, beta cell function declines, and drugs that depend on squeezing more insulin out of the pancreas start to lose their effect. Diagnosis rests on laboratory measurement rather than symptoms. HbA1c of 6.5 percent or above, fasting plasma glucose of 126 mg/dL or above, or a two hour value of 200 mg/dL or above on an oral glucose tolerance test each meet the threshold, usually confirmed on a second occasion. A large share of people meet these criteria for years before diagnosis, which is why complications are sometimes present at the point of first diagnosis. The reason blood glucose is treated at all is complications, not the number itself. Sustained hyperglycaemia damages small vessels in the retina, kidneys and peripheral nerves, and contributes to large vessel disease affecting the heart, brain and limbs. Nerve and vascular damage is also the mechanism behind the strong association between long standing diabetes and erectile dysfunction in men. Medication is one part of management and rarely the whole of it. Diet, physical activity, weight, blood pressure and lipids all act on the same complication risk, and every approved diabetes drug is labelled as an adjunct to diet and exercise rather than a replacement for them. What medication does is bring glucose into a range where the damage slows, and keep it there as the underlying condition progresses.
!Symptoms
- •Increased thirst and frequent urination, particularly at night
- •Persistent fatigue that does not improve with rest
- •Unexplained weight loss despite normal or increased appetite
- •Blurred vision that fluctuates with blood glucose levels
- •Slow healing of cuts, grazes and skin infections
- •Recurrent thrush, urinary tract infections or skin infections
- •Numbness, tingling or burning pain in the feet and hands
- •Darkened velvety skin patches in the neck folds or armpits
- •Erectile dysfunction or reduced sexual function in men
- •No symptoms at all, which is common and why screening exists
?Causes & Risk Factors
- •Insulin resistance, where muscle, liver and fat tissue respond poorly to insulin
- •Progressive decline in pancreatic beta cell function over years
- •Excess body weight, particularly visceral fat around the abdomen
- •Physical inactivity, which reduces glucose uptake by muscle
- •Family history of type 2 diabetes, which carries substantial genetic weight
- •Age above 45, although diagnosis in younger adults is rising
- •South Asian, African, African Caribbean and Hispanic ancestry, where risk rises at lower body weight
- •Previous gestational diabetes or delivery of a large birthweight baby
- •Polycystic ovary syndrome, which involves the same insulin resistance mechanism
- •Long term corticosteroid or antipsychotic treatment
Treatment Options
Six oral drug classes cover most type 2 diabetes prescribing, and they are not interchangeable. Biguanides. Metformin reduces hepatic glucose output and improves insulin sensitivity. It is first line in almost every guideline, does not cause hypoglycaemia on its own, and is broadly weight neutral. Its weakness is early gastrointestinal upset, reported as diarrhoea in 53.2 percent of patients on immediate release tablets against 11.7 percent on placebo, which is why slow titration and the extended release form both exist. It is contraindicated below an eGFR of 30. Sulfonylureas. Glimepiride, gliclazide, glipizide and glibenclamide bind the sulfonylurea receptor on beta cells and force insulin release. They lower HbA1c quickly and cost very little. Because the insulin release is not glucose dependent, they cause genuine hypoglycaemia, and because they need working beta cells, they lose effect over years. DPP-4 inhibitors. Sitagliptin, vildagliptin, linagliptin, saxagliptin and teneligliptin raise incretin levels, increasing insulin release only when glucose is high. Well tolerated and weight neutral, with modest glucose lowering. SGLT2 inhibitors. Empagliflozin, dapagliflozin and canagliflozin make the kidney excrete glucose in urine. They lower weight and blood pressure, and this class has dedicated cardiovascular and kidney outcome data. Main risks are genital fungal infection and, rarely, ketoacidosis. Thiazolidinediones. Pioglitazone improves insulin sensitivity directly. Effective and durable, with fluid retention, weight gain, heart failure and fracture risk to weigh. Alpha glucosidase inhibitors and glinides. Acarbose, miglitol, voglibose, repaglinide and nateglinide target post meal glucose specifically. Fixed dose combinations pair metformin with one of the others in a single tablet. They simplify a regimen but inherit the warnings of both components, and their metformin content still counts towards the metformin daily ceiling.
Medications for Type 2 Diabetes
Glycomet 500mg
Metformin · 500mg
USV Pvt Ltd
$38
USD
Glycomet 1000mg
Metformin · 1000mg
USV Pvt Ltd
$69
USD
Glycomet 500mg SR
Metformin · SR
USV Pvt Ltd
$66
USD
Amaryl 2mg
Glimepiride · 2mg
Sanofi India Limited
$37
USD
Glycomet-GP 1
Metformin/Glimepiride · 1 mg
USV Pvt Ltd
$40
USD
Januvia 100mg
Sitagliptin · 100mg
MSD Pharmaceuticals Pvt. Ltd.
$74
USD
Jardiance 25mg
Empagliflozin · 25mg
Boehringer Ingelheim India Pvt.Ltd
$68
USD
Forxiga 10mg
Dapagliflozin · 10mg
AstraZeneca Pharma India Ltd
$88
USD
Glizid 80mg
Gliclazide · 80mg
Panacea Biotech Ltd.
$19
USD
Pioz 15mg
Pioglitazone · 15mg
USV Pvt. Ltd.
$20
USD
Why Choose Generic?
Type 2 diabetes is treated for decades, not weeks, so the price of a daily tablet compounds into a large number. That makes it the clearest case in medicine for generic and internationally sourced brands. Metformin, glimepiride, gliclazide, glipizide, pioglitazone and acarbose have been off patent for years and are available as inexpensive generics that national health systems use as standard. A generic contains the same active ingredient at the same strength as the originator and must meet the same bioequivalence standard. Several products stocked here are the originator brand made under licence for the Indian market by the same company that owns the brand, including Amaryl from Sanofi, Januvia from MSD, Jardiance from Boehringer Ingelheim and Forxiga from AstraZeneca. These are the genuine branded medicine at Indian market pricing rather than a copy. All products require a valid prescription, and diabetes should be managed with a prescriber who can monitor kidney function, HbA1c and vitamin B12.
Frequently Asked Questions
What is the first medicine used for type 2 diabetes?
Metformin, in almost every clinical guideline, unless it is contraindicated or not tolerated. It reduces the glucose the liver produces and improves insulin sensitivity, does not cause hypoglycaemia on its own, and is inexpensive. It is contraindicated when eGFR falls below 30 mL/min/1.73 m2.
Which type 2 diabetes tablets cause low blood sugar?
Mainly the sulfonylureas, including glimepiride, gliclazide, glipizide and glibenclamide, and the glinides such as repaglinide and nateglinide. They release insulin regardless of the current glucose level. Metformin, DPP-4 inhibitors and SGLT2 inhibitors rarely cause hypoglycaemia when used alone.
Do any diabetes tablets help with weight?
SGLT2 inhibitors such as empagliflozin and dapagliflozin are associated with modest weight loss because glucose is excreted in urine. Metformin is broadly weight neutral. Sulfonylureas and pioglitazone are associated with weight gain, which is a real consideration if weight is part of the treatment plan.
Why do diabetes medicines stop working after a few years?
Beta cell function declines over the course of type 2 diabetes. Drugs that work by stimulating insulin release, chiefly the sulfonylureas, gradually lose potency as there is less capacity left to stimulate. This is why treatment is usually intensified over time rather than kept static.
What is a combination diabetes tablet?
A single tablet containing metformin plus one other agent, such as glimepiride, sitagliptin, vildagliptin, empagliflozin or pioglitazone. It reduces the number of tablets taken but carries the warnings of both components, and the metformin it contains still counts towards the daily metformin limit.
Does kidney function affect which tablets can be used?
Yes, substantially. Metformin is contraindicated below an eGFR of 30 and starting it is not recommended between 30 and 45. Sulfonylureas need lower starting doses in renal impairment because their effect is prolonged. SGLT2 inhibitors have their own eGFR thresholds for glucose lowering benefit. Kidney function should be checked before starting and at least annually.
Can type 2 diabetes medicines be bought without a prescription?
No. Metformin, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors and pioglitazone all require a prescription in the United States, United Kingdom, Canada and Australia. Customers are responsible for complying with their local regulations. Diabetes needs monitoring that only a prescriber can provide.
Are generic diabetes medicines as effective as the branded versions?
Yes. A generic contains the same active ingredient at the same strength and must meet the same bioequivalence standard as the originator. Generic metformin, glimepiride and gliclazide are the standard supply in national health systems worldwide.
Related Guides
Medical Disclaimer: This page is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting, changing, or stopping any medication. Individual responses to treatment vary. SafeRxPills is an online pharmacy, we do not diagnose conditions or provide medical consultations.